Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults

Clinical trial NCT01983514 · COMPLETED

Trial details

NCT number: NCT01983514
Sponsor: OptiNose AS
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male Adults

Start date: 2013-10-01
Primary completion: 2014-02-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.